Explore more publications!

Washington State Politics: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Washington State Politics.

Press releases published on October 31, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 17, 2025 in Cytokinetics Lawsuit – CYTK
ROSEN, A LEADING AND RANKED FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
FCX Investor News: If You Have Suffered Losses in Freeport-McMoRan Inc. (NYSE: FCX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Cepton, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CPTN
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages RCI Hospitality Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – RICK
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Quanex Building Products Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NX
NOVARC REVEALS THE WORLD’S FIRST FULLY AUTONOMOUS TIG WELDING SOLUTION BUILT IN BRITISH COLUMBIA
JHX Investors Have Opportunity to Lead James Hardie Industries plc Securities Fraud Lawsuit with the Schall Law Firm
AVTR Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Avantor, Inc.
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
KBR, Inc. (KBR) Cuts 2025 Revenue Due to TRANSCOM Termination, Securities Class Action Looms–Hagens Berman
ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman
Fiserv, Inc. (FI) Former CEO Sold 2.6M Shares For $423M Before Company’s “‘Abysmal’” Q3 2025 Results – Hagens Berman
James Hardie Industries (JHX) Lawsuit Alleges Securities Fraud Over Inventory Misstatements – Hagens Berman
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate – Hagens Berman
WPP Investors Have Opportunity to Lead WPP plc Securities Fraud Lawsuit with the Schall Law Firm
MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit with the Schall Law Firm
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Mountain America’s Seventh Annual Month of Caring Program Unites Communities Across Five States

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions